TY - JOUR
T1 - Is cardiac resynchronization therapy for right ventricular failure in pulmonary arterial hypertension of benefit?
AU - Rasmussen, Jason T
AU - Thenappan, Thenappan
AU - Benditt, David G.
AU - Weir, Edward K
AU - Pritzker, Marc R.
N1 - Publisher Copyright:
© 2014 by the Pulmonary Vascular Research Institute. All rights reserved.
PY - 2014/12
Y1 - 2014/12
N2 - Pulmonary arterial hypertension is a manifestation of a group of disorders leading to pulmonary vascular remodeling and increased pulmonary pressures. The right ventricular (RV) response to chronic pressure overload consists of myocardial remodeling, which is in many ways similar to that seen in left ventricular (LV) failure. Maladaptive myocardial remodeling often leads to intraventricular and interven-tricular dyssychrony, an observation that has led to cardiac resynchronization therapy (CRT) for LV failure. CRT has proven to be an effective treatment strategy in subsets of patients with LV failure resulting in improvement in LV function, heart failure symptoms, and survival. Current therapy for pulmonary arterial hypertension is based on decreasing pulmonary vascular resistance, and there is currently no effective therapy targeting the right ventricle or maladaptive ventricular remodeling in these patients. This review focuses on the RV response to chronic pressure overload, its effect on electromechanical coupling and synchrony, and how lessons learned from left ventricular cardiac resynchronization might be applied as therapy for RV dysfunction in the context ofpulmonary arterial hypertension.
AB - Pulmonary arterial hypertension is a manifestation of a group of disorders leading to pulmonary vascular remodeling and increased pulmonary pressures. The right ventricular (RV) response to chronic pressure overload consists of myocardial remodeling, which is in many ways similar to that seen in left ventricular (LV) failure. Maladaptive myocardial remodeling often leads to intraventricular and interven-tricular dyssychrony, an observation that has led to cardiac resynchronization therapy (CRT) for LV failure. CRT has proven to be an effective treatment strategy in subsets of patients with LV failure resulting in improvement in LV function, heart failure symptoms, and survival. Current therapy for pulmonary arterial hypertension is based on decreasing pulmonary vascular resistance, and there is currently no effective therapy targeting the right ventricle or maladaptive ventricular remodeling in these patients. This review focuses on the RV response to chronic pressure overload, its effect on electromechanical coupling and synchrony, and how lessons learned from left ventricular cardiac resynchronization might be applied as therapy for RV dysfunction in the context ofpulmonary arterial hypertension.
KW - Cardiac resynchronization therapy
KW - Dyssyn-chrony
KW - Pulmonary arterial hypertension
KW - Pulmonary hypertension
KW - Right ventricular failure
UR - http://www.scopus.com/inward/record.url?scp=85026335812&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85026335812&partnerID=8YFLogxK
U2 - 10.1086/678470
DO - 10.1086/678470
M3 - Review article
AN - SCOPUS:85026335812
SN - 2045-8932
VL - 4
SP - 552
EP - 559
JO - Pulmonary Circulation
JF - Pulmonary Circulation
IS - 4
ER -